ALFA Finder| Value | ₹93.23 Cr |
|---|
BSE filing, NSE: KABRADG. Summary written from the filing by ALFA Finder's alert engine.
Kabra Drugs Ltd: key numbers
- Share price
- ₹18.15
- Market cap
- ₹43.03 Cr
- Revenue (annual)
- ₹92.74 Cr
- Net profit (annual)
- ₹4.96 Cr
- P/E (TTM)
- 5.6×Sector 43.8×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kabra Drugs Ltd
All →Kabra Drugs Q2 FY27 Results: Net Profit ₹1.9 Cr, Up 5.6% YoY
Kabra Drugs Ltd reported revenue from operations of ₹32 Cr (+61.6% YoY) and net profit of ₹1.9 Cr (+5.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.9 Cr · +5.6% YoY
Kabra Drugs Board Meeting Date
Kabra Drugs (now Aanjaay Industries) intimated a board meeting on 6 November 2026 to consider unaudited results for the quarter ended 30 September 2026. The filing is advance notice only.
Kabra Drugs Other Announcement
The company has filed its quarterly shareholding pattern for the period ending September 30, 2026. The document discloses the distribution of shareholding among various categories of investors.
Kabra Drugs Annual General Meeting
Aanjaay Industries Limited conducted its 37th Annual General Meeting on September 30, 2026. Shareholders transacted business including the adoption of financial statements and director appointments.
Kabra Drugs Annual Report
Aanjaay Industries Ltd has submitted its Annual Report for FY 2025-2026 and issued notice for its 37th AGM scheduled for 30th September 2026.
Kabra Drugs Annual General Meeting
Aanjaay Industries Limited announced book closure dates from September 24th to September 30th, 2026, for its Annual General Meeting scheduled for September 30th, 2026.
Other results update announcements
All →Namo eWaste Management Results Update
Namo eWaste reported 40% YoY revenue growth to Rs.1,224.7 Mn in H1FY27. EBITDA and PAT rose 33% and 29% YoY respectively.
- total e-waste/battery processing capacity
- 82000 MTPA
R M Drip and Sprinklers Systems Results Update
R M Drip's Q2 FY27 PBT fell to ₹29.08 Crore on raw material cost hikes and drought. Revenue was ₹322.22 Crore with 30.58% gross margin.
Lakshya Powertech Results Update
Lakshya Powertech announced H1 FY27 financial results via press release. New orders aggregating ₹972 Crore were secured during the period.
- Order book
- ₹953.0 Cr
NAVA Results Update
Nava reports record Q2 revenue of ₹1,252 Crore and PAT up 127% YoY to ₹403 Crore. Its 100 MW Zambia solar project reached commercial operation.
- solar capacity commissioned
- 100 MW
Glottis Results Update
Glottis reported Q2 FY27 revenue of ₹2,765 million, up 28.8% YoY, but EBITDA fell to ₹34 million. PAT was a loss of ₹0.2 million for the quarter.
Lotus Eye Hospital and Institute Results Update
Lotus Eye Hospital reported Q2 FY27 revenue of ₹17.72 crore, up 36%, with net profit of ₹43.95 lakh. Half-year net profit rose 59% to ₹1.05 crore.